Niranjan Kanesa-thasan, Chief Medical Officer at Icosavax, Inc. (ICVX), sold 3,245 shares at $6.64 ($22K) on 2022-08-01, disclosed to the SEC on 2022-08-02.
Scheduled sale ($22k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.11 | 701 | $5K | 22.7% |
| 2 | $6.64 | 2,001 | $13K | 60.6% |
| 3 | $6.70 | 543 | $4K | 16.6% |
| Total | $6.75 avg | 3,245 | $22K | 100% |
| Filing → |
| ICVX | SELL | 2023-08-01 | $29K | — | Filing → |
| ICVX | SELL | 2023-02-15 | $19K | — | Filing → |
| ICVX | BUY | 2021-08-02 | $100K | — | Filing → |